| Prevalence and impact of diabetes among people infected with SARS-CoV-2 GP Fadini, ML Morieri, E Longato, A Avogaro Journal of endocrinological investigation 43, 867-869, 2020 | 628 | 2020 |
| Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration GP Fadini, ML Morieri, F Boscari, P Fioretto, A Maran, L Busetto, ... Diabetes research and clinical practice 168, 108374, 2020 | 226 | 2020 |
| Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: a case‐control study GP Fadini, ML Morieri, E Longato, BM Bonora, S Pinelli, E Selmin, ... Diabetes, Obesity and Metabolism 22 (10), 1946-1950, 2020 | 109 | 2020 |
| Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population A Passaro, E Dalla Nora, ML Morieri, C Soavi, JM Sanz, A Zurlo, R Fellin, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2015 | 82 | 2015 |
| PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome. A Passaro, E Dalla Nora, C Marcello, F Di Vece, ML Morieri, JM Sanz, ... Cardiovascular Diabetology 10, 8, 2011 | 58 | 2011 |
| Gene expression regional differences in human subcutaneous adipose tissue A Passaro, MA Miselli, JM Sanz, E Dalla Nora, ML Morieri, R Colonna, ... BMC genomics 18, 1-11, 2017 | 57 | 2017 |
| Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: findings from the ACCORD clinical trial HS Shah, H Gao, ML Morieri, J Skupien, S Marvel, G Paré, GC Mannino, ... Diabetes Care 39 (11), 1915-1924, 2016 | 53 | 2016 |
| Variants in ANGPTL4 and the Risk of Coronary Artery Disease. ML Morieri, H Shah, D Alessandro, AGS Group. New England Journal of Medicine 375 (23), 2304-2305, 2016 | 51* | 2016 |
| Interleukin-6 “trans-signaling” and ischemic vascular disease: the important role of soluble gp130 ML Morieri, A Passaro, G Zuliani Mediators of inflammation 2017, 2017 | 48 | 2017 |
| Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes DM Rotroff, SS Pijut, SW Marvel, JR Jack, TM Havener, A Pujol, ... Clinical Pharmacology & Therapeutics 103 (4), 712-721, 2018 | 45 | 2018 |
| Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature medicine 29 (10), 2438-2457, 2023 | 42 | 2023 |
| Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults G Zuliani, ML Morieri, S Volpato, M Maggio, A Cherubini, D Francesconi, ... Atherosclerosis 235 (2), 538-545, 2014 | 41 | 2014 |
| Genetic tools for coronary risk assessment in type 2 diabetes: a cohort study from the ACCORD clinical trial ML Morieri, H Gao, M Pigeyre, HS Shah, J Sjaarda, C Mendonca, ... Diabetes Care 41 (11), 2404-2413, 2018 | 37 | 2018 |
| Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study G Zuliani, ML Morieri, S Volpato, GB Vigna, CB Tch, M Maggio, ... Atherosclerosis 226 (1), 201-207, 2013 | 37 | 2013 |
| PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid ML Morieri, HS Shah, J Sjaarda, PA Lenzini, H Campbell, ... Diabetes 69 (4), 771-783, 2020 | 33 | 2020 |
| The toll of lockdown against COVID-19 on diabetes outpatient care: analysis from an outbreak area in northeast Italy. BM Bonora, ML Morieri, A Avogaro, GP Fadini | 32 | 2021 |
| Lower plasma Klotho concentrations are associated with vascular dementia but not late-onset Alzheimer’s disease G Brombo, F Bonetti, B Ortolani, ML Morieri, C Bosi, A Passaro, GB Vigna, ... Gerontology 64 (5), 414-421, 2018 | 32 | 2018 |
| Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage C Cervellati, GB Vigna, A Trentini, JM Sanz, F Zimetti, E Dalla Nora, ... Atherosclerosis 285, 64-70, 2019 | 31 | 2019 |
| Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies ML Morieri, M Rigato, V Frison, N Simioni, M D'Ambrosio, F Tadiotto, ... Metabolism 106, 154190, 2020 | 28 | 2020 |
| Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of … ML Morieri, A Avogaro, GP Fadini, ... Cardiovascular Diabetology 19, 1-14, 2020 | 26 | 2020 |
